TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from TNF Pharmaceuticals ( (TNFA) ) is now available.
On March 6, 2025, TNF Pharmaceuticals held a telephonic conference call to discuss the progress of their lead compound, Isomyosamine. The company provided updates on their research and development efforts, but emphasized that the information shared is not necessarily material or required to be disclosed under regulatory obligations.
More about TNF Pharmaceuticals
TNF Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the research and development of medical compounds, with a primary emphasis on their lead compound, Isomyosamine.
YTD Price Performance: -67.83%
Average Trading Volume: 537,931
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.02M
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.